Sungchae Hong
发表
Jaewon Lee,
N. Ha,
Yunjin Jung,
2011,
Biochemical pharmacology.
Wooseong Kim,
Yunjin Jung,
S. Yum,
2015,
European journal of pharmacology.
Yunjin Jung,
Hyesik Kong,
Young Mi Kim,
2009,
Journal of drug targeting.
Yunjin Jung,
Hyesik Kong,
Young Mi Kim,
2009,
Pharmaceutical Research.
Yunjin Jung,
Young Mi Kim,
Sungchae Hong,
2009,
European journal of pharmacology.
M. Kwak,
Jeong-eun Oh,
Wooseong Kim,
2013,
Free radical biology & medicine.
Dae-Duk Kim,
Yunjin Jung,
Jeong‐Hyun Yoon,
2012,
The Journal of pharmacy and pharmacology.
Yunjin Jung,
Jihye Kim,
Young Mi Kim,
2012,
European journal of medicinal chemistry.
Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.
Yunjin Jung,
Jeong‐Hyun Yoon,
S. Yum,
2012,
Molecular pharmaceutics.
Ji-Hye Kim,
Youna Lee,
Yunjin Jung,
2010,
European journal of pharmacology.
Yunjin Jung,
Jung-Suk Choi,
Young Mi Kim,
2010,
The Journal of nutritional biochemistry.
Wooseong Kim,
Yunjin Jung,
S. Yum,
2014,
Biochemical and biophysical research communications.
Jung-Ae Kim,
Yunjin Jung,
Jung-Suk Choi,
2009,
Toxicology and applied pharmacology.
Dae-Duk Kim,
Yunjin Jung,
S. Yum,
2013,
European journal of pharmacology.
Wooseong Kim,
Yunjin Jung,
Jeong‐Hyun Yoon,
2014,
European journal of pharmacology.
Yunjin Jung,
Young Mi Kim,
Sungchae Hong,
2009,
Journal of pharmaceutical sciences.
N. Ha,
Yunjin Jung,
S. Yum,
2010,
Analytical biochemistry.
Yunjin Jung,
Jeong‐Hyun Yoon,
Yonghyun Lee,
2011,
Biopharmaceutics & drug disposition.
Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.
Yunjin Jung,
Jeong‐Hyun Yoon,
S. Yum,
2012,
Molecular pharmaceutics.